- Home
- CJET vs DOMH Comparison
CJET vs DOMH Comparison
Compare CJET & DOMH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CJET
- DOMH
- Stock Information
- Founded
- CJET 2009
- DOMH 1967
- Country
- CJET China
- DOMH United States
- Employees
- CJET N/A
- DOMH N/A
- Industry
- CJET Auto Manufacturing
- DOMH Biotechnology: Pharmaceutical Preparations
- Sector
- CJET Consumer Discretionary
- DOMH Health Care
- Exchange
- CJET Nasdaq
- DOMH Nasdaq
- Market Cap
- CJET 11.1M
- DOMH 12.1M
- IPO Year
- CJET N/A
- DOMH N/A
- Fundamental
- Price
- CJET $1.98
- DOMH $1.71
- Analyst Decision
- CJET
- DOMH
- Analyst Count
- CJET 0
- DOMH 0
- Target Price
- CJET N/A
- DOMH N/A
- AVG Volume (30 Days)
- CJET 16.5K
- DOMH 9.7K
- Earning Date
- CJET 12-02-2024
- DOMH 11-08-2024
- Dividend Yield
- CJET N/A
- DOMH N/A
- EPS Growth
- CJET N/A
- DOMH N/A
- EPS
- CJET N/A
- DOMH N/A
- Revenue
- CJET $10,275,000.00
- DOMH $12,589,000.00
- Revenue This Year
- CJET N/A
- DOMH N/A
- Revenue Next Year
- CJET N/A
- DOMH N/A
- P/E Ratio
- CJET N/A
- DOMH N/A
- Revenue Growth
- CJET 31.31
- DOMH 1117.50
- 52 Week Low
- CJET $1.77
- DOMH $1.50
- 52 Week High
- CJET $68.70
- DOMH $3.20
- Technical
- Relative Strength Index (RSI)
- CJET 45.07
- DOMH 40.13
- Support Level
- CJET $1.94
- DOMH $1.52
- Resistance Level
- CJET $2.42
- DOMH $1.69
- Average True Range (ATR)
- CJET 0.18
- DOMH 0.09
- MACD
- CJET 0.02
- DOMH -0.01
- Stochastic Oscillator
- CJET 22.92
- DOMH 32.14
About CJET Chijet Motor Company Inc.
Chijet Motor Co Inc is engaged in the research and development, production and sales of new energy vehicles. New energy vehicles refer to plug-in electric vehicles including battery electric vehicles, plug-in hybrid (PHEV) electric vehicles, and fuel cell electric vehicles. Its passenger vehicles include small cars, sedans, and sports utility vehicles, or SUVs, and commercial vehicles include light trucks and vans.
About DOMH Dominari Holdings Inc.
Dominari Holdings Inc is a biotechnology company with a diverse portfolio of small-molecule anticancer and antiviral therapeutics in development. The company's oncology therapeutics include treatments for pancreatic cancer, acute myeloid leukemia, and acute lymphoblastic leukemia.